Clinion Wins SCDM 2024 Innovation Award: Recognized for Excellence in Clinical Data Science
The SCDM Innovation Awards are designed to recognize those organizations that have demonstrated the highest level of integration of Clinical Data Science, driving substantial progress towards its realization, through their people, processes, or technology.
We are pleased to announce that Clinion has been recognized with the SCDM 2024 Innovation Award for Clinical Data Science Implementation Excellence. This recognition highlights our pioneering role in revolutionizing clinical trial management through AI and Gen AI integration.
Clinion: A New Standard in Clinical Trial Management
Clinion is the world’s first AI-enabled eClinical platform that integrates advanced AI and Gen AI technologies as a core of the product, setting us apart from traditional solutions. By embedding AI directly into our platform, Clinion EDC offers a transformative approach to clinical trial data management from study setup to close-out, ensuring a reduction in trial timelines and costs while enhancing efficiency. Clinion EDC is pioneering a new era in trial management, where cutting-edge AI drives superior results and redefines industry standards.
Clinion’s Commitment to Innovation
Manuj Vangipurapu, Founder & CEO of Clinion, commented on the award: “We are honored to receive the SCDM Innovation Award. This recognition reflects our commitment to pushing the boundaries of clinical data management through advanced AI and automation. Our mission has always been to simplify complex trial processes while ensuring the highest data accuracy and operational efficiency. This award validates our efforts and inspires us to continue delivering solutions that revolutionize the industry.”
What Makes Clinion Stand Out?
Clinion addresses critical challenges in clinical trial management—long timelines, high costs, and error-prone manual processes—by replacing traditional methods with AI-driven automation. Here are the few areas Clinion uses AI to streamline processes:
CDASH Annotation with AI
Clinion’s AI-driven CDASH Annotation simplifies the creation of annotated Case Report Forms (CRFs), an essential but traditionally manual task. Our AI automatically maps study data to CDASH standards, reducing human error and improving compliance. This automation cuts down the time required to prepare annotations and ensures that CRFs are consistent and adhere to industry standards, accelerating study setup timelines by 30%.
Gen AI-Powered Data Review: Empowering Data Managers
Historically, data managers have relied on biostatisticians for dataset creation for data review, creating bottlenecks that delayed critical decision-making. Clinion has developed a revolutionary Gen AI driven data review tool which tackles this challenge by allowing data managers to generate datasets and raise queries instantly. Data Managers can create any kind of dataset by providing simple english prompts which the AI tool understands and constructs the dataset. The data manager can then review the data and raise queries from the dataset itself!
With self-serve ability for data managers, data review processes are accelerated, improving data quality and saving hours of manual effort.
Dynamic Reporting with Gen AI: Real-Time Insights
Traditional reporting methods are often slow and complex, delaying the availability of actionable insights. Clinion EDC’s Gen AI technology addresses this by allowing data managers to generate custom reports and visualizations on the fly. These reports can be saved and scheduled to run at regular intervals. Different stakeholders can access these dynamic reports in real time, making it easier to make informed decisions quickly and efficiently.
A New Era in Clinical Trial Management
Clinion EDC is driving a new standard in clinical trial management, where AI and automation replace traditional methods, enabling faster, more efficient trials. With Clinion, sponsors and CROs can look forward to reduced timelines, lower costs, and higher-quality data—ushering in a future where AI powers superior clinical outcomes.
